 idiopath thrombocytopen purpura pregnanc random trial effect antenat low dose corticosteroid neonat platelet count object efficaci antenat low dose oral betamethason neonat thrombocytopenia and/or bleed infant mother idiopath thrombocytopen purpura itp set hospit depart obstetr gynaecolog referr centr patient pregnanc women result pregnanc non-assess final analysi betamethason group non-treat group criteria itp intervent treat group mg day day till day mg day till deliveri main outcom measur effect treatment term matern platelet count first trimest neonat platelet count birth first week life neonat bleed episod result signific differ neonat platelet count birth infant betamethason group untreat group sever thrombocytopenia birth first week life /l seven infant betamethason group non-treat group mild thrombocytopenia overal frequenc neonat thrombocytopenia similar betamethason group untreat group CI true differ signific differ neonat bleed episod conclus low-dos betamethason pregnant women itp thrombocytopenia bleed newborn infant